FDA Accelerates Review of Serious Mental Illness Treatments Following Executive Order
β’ President Trump issued an Executive Order directing the Department of Health and Human Services to expedite access to treatments for patients with serious mental illness. β’ The FDA is accelerating its review process for mental health therapies in response to the directive. β’ This policy shift aims to reduce barriers to treatment approval and expand therapeutic options for affected patients.
Read original Β· hhs.gov



